OX
Oxford BioDynamics Plc
OXBOF · OTC
$0.00 +0.00% (+$0.00)
Market Cap £2.52M
P/E Ratio -
Div. Yield -
ROE 304.26%
Piotroski F-Score Weak
3/9Valuation
76 /100
Cheap P/S 2.30x
P/B 2.26x
P/E N/A
Growth
78 /100
Growing Rev. growth 92.29%
Book val. growth 24.45%
EPS growth N/A
Profitability
19 /100
Weak Gross margin 47.67%
FCF margin 713.88%
Net margin 1,018.54%
Quality
2 /100
Poor ROIC 134.24%
Asset turnover 0.14x
ROE 304.26%
Debt
7 /100
High Debt/Equity 4.58x
Int. coverage -26.07x
Current ratio 0.88x
Stability
26 /100
Unstable Beta -0.15x
Profitable years 0
Rev. volatility 108.14%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about OXBOF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Richard Compton
Employees
51
Headquarters
Oxford
Upcoming events
26 JAN
Earnings
Upcoming earnings report